SCHEMBL784122

SCHEMBL784122

Cc1cc(N2CCC(N(C)C(=O)c3ccc4c(c3)C(NS(=O)(=O)Cc3ccccc3F)CC4)CC2)cc(C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 3/20 0.37
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
HSD17B10 Q99714 1/20 0.36
RORC P51449 1/20 0.35
NR1H3 Q13133 1/20 0.35
RORB Q92753 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
EPHX2 P34913 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
JAK1 P23458 1/20 0.35
CCR3 P51677 1/20 0.34
NPY5R Q15761 2/20 0.34
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785538 0.91 EPHX2 (0.44) F10TLR9TLR8TLR7RORC
SCHEMBL784016 0.88 F10 (0.43) F10TLR9TLR8TLR7JAK1
SCHEMBL784247 0.87 RORC (0.36) F10MEN1KMT2AL3MBTL1RORC
SCHEMBL785585 0.85 F10 (0.42) F10TLR9TLR8TLR7RORC
SCHEMBL784459 0.85 GALR3 (0.41) F10MEN1KMT2ATLR9TLR8
SCHEMBL27920389 0.83 EPHX2 (0.37) F10TLR9TLR8TLR7EPHX2
SCHEMBL785628 0.82 F10 (0.37) F10KMT2ARORCEPHX2JAK1
SCHEMBL784928 0.81 TLR9 (0.43) F10TLR9TLR8TLR7JAK1
SCHEMBL784022 0.80 TLR9 (0.42) F10TLR9TLR8TLR7JAK1
SCHEMBL784495 0.79 RORC (0.36) F10RORCEPHX2JAK1CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 F10 524/4885MEN1 2563/4885KMT2A 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.